SALVETTI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 12.156
EU - Europa 3.707
AS - Asia 1.359
AF - Africa 98
SA - Sud America 61
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 5
Totale 17.400
Nazione #
US - Stati Uniti d'America 12.078
IT - Italia 1.653
SE - Svezia 622
IN - India 580
CN - Cina 476
UA - Ucraina 387
FI - Finlandia 296
DE - Germania 196
SG - Singapore 190
GB - Regno Unito 117
BG - Bulgaria 94
TG - Togo 78
CA - Canada 63
IE - Irlanda 62
AR - Argentina 57
RO - Romania 54
FR - Francia 36
AT - Austria 34
TR - Turchia 30
NL - Olanda 27
TW - Taiwan 27
BE - Belgio 21
HK - Hong Kong 17
RU - Federazione Russa 17
CH - Svizzera 14
PL - Polonia 14
AU - Australia 11
ES - Italia 11
GR - Grecia 10
MX - Messico 10
CZ - Repubblica Ceca 8
ZA - Sudafrica 8
IR - Iran 7
SC - Seychelles 7
IL - Israele 6
JP - Giappone 6
PT - Portogallo 6
AL - Albania 5
RS - Serbia 5
VN - Vietnam 5
EU - Europa 4
MK - Macedonia 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
EG - Egitto 3
NZ - Nuova Zelanda 3
CI - Costa d'Avorio 2
CR - Costa Rica 2
EE - Estonia 2
HU - Ungheria 2
ID - Indonesia 2
IS - Islanda 2
NO - Norvegia 2
PR - Porto Rico 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
HR - Croazia 1
IQ - Iraq 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
PA - Panama 1
PK - Pakistan 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 17.400
Città #
Fairfield 2.092
Ashburn 1.437
Chandler 950
Woodbridge 937
Houston 753
Seattle 747
Cambridge 701
Wilmington 606
Rome 502
Ann Arbor 422
Princeton 360
Beijing 359
Fasano 297
Plano 258
Lawrence 205
Boston 202
San Paolo di Civitate 201
San Diego 166
Jacksonville 153
Dearborn 108
Norwalk 108
Millbury 106
Andover 100
Sofia 93
New York 80
Lomé 78
Singapore 78
Helsinki 75
Dublin 56
Federal 56
Toronto 55
Milan 54
Des Moines 48
Falls Church 45
Bremen 34
Boardman 33
Bühl 29
Vienna 28
Grafing 27
San Mateo 27
Taipei 26
Phoenix 24
Pune 23
Nanjing 19
Istanbul 18
Brussels 17
Varedo 17
Naples 15
Hong Kong 14
Hefei 13
Kunming 13
Latina 13
London 13
Edinburgh 10
Redwood City 10
Buffalo 9
Guangzhou 9
Los Angeles 9
Paris 9
Warsaw 9
Ahmedabad 8
Giugliano In Campania 8
Redmond 8
Civitavecchia 7
Laurel 7
Mexico City 7
Ponzano Veneto 7
Verona 7
Bonndorf 6
Parma 6
Salerno 6
Southend 6
Zurich 6
Auburn Hills 5
Bologna 5
Champs-sur-marne 5
Fremont 5
Hanoi 5
Hebei 5
Jinan 5
Madrid 5
Nanchang 5
Oxford 5
Varese 5
Amsterdam 4
Atlanta 4
Bad Bellingen 4
Baotou 4
Catania 4
Chicago 4
Ercolano 4
Frankfurt am Main 4
Genoa 4
Genova 4
Indiana 4
Lappeenranta 4
Perugia 4
Prescot 4
Provo 4
Shrewsbury 4
Totale 13.164
Nome #
Collaboration between a human group and artificial intelligence can improve prediction of multiple sclerosis course. A proof-of-principle study 507
B cells and multiple sclerosis 119
Conversion from clinically isolated syndrome to multiple sclerosis. a large multicentre study. 111
Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study 107
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS 105
Riluzole in patients with hereditary cerebellar ataxia. a randomised, double-blind, placebo-controlled trial 103
Noise Enhances Action Potential Generation in Mouse Sensory Neurons via Stochastic Resonance 101
Machine learning use for prognostic purposes in multiple sclerosis 100
Dendritic cells loaded with apoptotic oligodendrocytes as a source of myelin T-cell epitopes in multiple sclerosis 96
Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor (IRF)-1 pathway in multiple sclerosis patients 96
Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases 96
The T cell response to amyloid-beta to mitochondrial antigens in Alzheimer's disease 93
IFN-β and multiple sclerosis: From etiology to therapy and back 93
Brainstem signs with progressing atrophy of medulla oblongata and upper cervical spinal cord 92
A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in multiple sclerosis 92
Increased circulating levels of vitamin D binding protein in MS patients 91
Involvement of the limbic system in multiple sclerosis patients with depressive disorders 90
EBNA2 binds to genomic intervals associated with multiple sclerosis and overlaps with vitamin D receptor occupancy 90
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 88
070 Baseline characteristics and safety profile of patients with relapsing-remitting multiple sclerosis (RRMS) in the first interim analysis of the peginterferon BETA-1A treatment in the phase 4 plegridy observational program (POP) 88
Twin studies in multiple sclerosis. A meta-estimation of heritability and environmentality 87
Epstein-Barr virus genetic variants are associated with multiple sclerosis 86
CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes. 85
Considering patient clinical history impacts performance of machine learning models in predicting course of multiple sclerosis 84
Early relapses after the first dose of natalizumab in active multiple sclerosis patients 83
CD161(high) CD8(+)T cells bear pathogenetic potential in multiple sclerosis 83
T cell response to N-formylated peptides in humans 80
The Italian Twin Project: From the personal identification number to a national Twin Registry 80
Bacterial vaccines for the treatment of multiple sclerosis and other autoimmune diseases. 79
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis. An Italian, Multicenter, Real-World Study 79
Characterization of Epstein–Barr virus genotypes in multiple sclerosis through next generation sequencing approaches 79
Multiple sclerosis in twins from continental Italy and Sardinia: a nationwide study 79
arsenical c-glucoside derivatives with promising antitumor activity 78
Screening for neurotropic viruses in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases 78
Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients 78
Drug holiday of interferon beta 1b in multiple sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority 78
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study 78
Refining genetic associations in multiple sclerosis 77
Antinuclear antibodies and MRI activity in multiple sclerosis. 77
Biomarkers for multiple sclerosis 76
HSP70-1 promoter region polymorphism tested in three autoimmune diseases 76
Multiple sclerosis progression is not associated with birth timing in Italy 76
Development of neutralizing antibodies in patients treated with IFN beta 1a 76
Novel homozygous GBA2 mutation in a patient with complicated spastic paraplegia 76
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML 75
Evidence for detrimental cross interactions between reactive oxygen and nitrogen species in Leber's hereditary optic neuropathy cells 75
determinant spreading without disease progression in multiple sclerosis 74
Coincident onset of multiple sclerosis and herpes simplex virus 1 encephalitis. a case report 74
Inverse correlation of genetic risk score with age at onset in bout-onset and progressiveonset multiple sclerosis 74
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis 74
A major influence of the T cell receptor repertoire as compared to antigen processing-presentation in the selection of myelin basic protein epitopes in multiple sclerosis. 74
The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function 74
T LYMPHOCYTE RESPONSE TO POTENTIAL AUTOANTIGENS IN PATIENTS WITH MULTIPLE SCLEROSIS. 73
Global immune disregulation in multiple sclerosis: from the adaptive response to the innate immunity 73
CD28 individual signals amplify pro-inflammatory cytokine production in relapse-remitting multiple sclerosis T lymphocytes. 73
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials 73
The contribution of gut barrier changes to multiple sclerosis pathophysiology 73
Development of Neutralizing Antibodies in Patients with Relapsing-Remitting Multiple Sclerosis Treated with IFN-β1a 72
Acetylcholine receptor-specific T-lymphocyte clones in the normal human immune repertoire: target epitopes, HLA restriction and membrane phenotypes 72
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS. 72
IFN-β Therapy Regulates TLR7-Mediated Response in Plasmacytoid Dendritic Cells of Multiple Sclerosis Patients Influencing an Anti-Inflammatory Status 72
Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up 72
The Impact of Interferon Beta and Natalizumab on Comorbid Migraine in Multiple Sclerosis 72
Lymphoid chemokines in chronic neuroinflammation 71
Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins 71
The burden of multiple sclerosis variants in continental Italians and Sardinians 71
Vaccines in multiple sclerosis. The experience of BCG vaccination 71
Bridging the gap between vaccination with Bacille Calmette-Guérin (BCG) and immunological tolerance: the cases of type 1 diabetes and multiple sclerosis 71
Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab 70
Bacille calmette guerin (BCG) vaccine in multiple sclerosis (MS): A single crossover study 70
A controlled study of potential risk factors preceding exacerbation in multiple sclerosis. 70
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome 70
HLA-class I markers and multiple sclerosis susceptibility in the Italian population 70
Variations of the perforin gene in patients with multiple sclerosis 69
Characterization of CD8+ T cell repertoire in identical twins discordant and concordant for multiple sclerosis. 69
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS. 69
null 69
Intestinal Permeabiliy in Relapsing-Remitting Multiple Sclerosis 69
Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients 69
Genetic burden of common variants in progressive and bout-onset multiple sclerosis 69
Genome-Wide Multiple Sclerosis Association Data and Coagulation 69
A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population. 69
Antiviral immune response in patients with multiple sclerosis, healthy siblings and twins 69
Multiple sclerosis etiology: beyond genes and environment 68
Systemic hypertension as a treatable risk factor for cerebrovascular disease. 68
Noise in multiple sclerosis: unwanted and necessary 68
null 68
Early diagnosis of progressive multifocal leucoencephalopathy. longitudinal lesion evolution 68
Chemical Elements and Oxidative Status in Neuroinflammation 68
The use of ID migraine (TM) questionnaire in patients with multiple sclerosis 68
Feasibility, Safety, and Effectiveness of Telerehabilitation in Mild-to-Moderate Parkinson's Disease 68
Determinants of the severity of comorbid migraine in multiple sclerosis 67
Proliferative response to heat shock proteins and gamma/delta T cell receptor expression of PPD specific T lymphocytes in multiple sclerosis 67
Association between vaccines and neuroinflammation. time, risks, and benefits 67
A perspective of coagulation dysfunction in multiple sclerosis and in experimental allergic encephalomyelitis 67
Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study 67
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. 67
Contribution of Genome-Wide Association Studies to Scientific Research: A Pragmatic Approach to Evaluate Their Impact 66
Author correction. Transcriptional dysregulation of interferome in experimental and human multiple sclerosis 66
Changing prognosis of primary intracerebral hemorrhage: results of a clinical and computed tomographic follow-up study of 104 patients. 66
Totale 8.196
Categoria #
all - tutte 48.385
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 315
selected - selezionate 0
volume - volumi 0
Totale 48.700


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.351 0 0 0 0 0 0 0 0 0 0 768 583
2019/20204.049 538 184 44 196 396 488 484 493 437 411 287 91
2020/20211.583 173 149 116 104 60 60 134 167 183 219 123 95
2021/20223.920 94 208 321 169 719 177 94 297 265 229 631 716
2022/20233.510 685 692 164 363 387 342 81 231 295 64 137 69
2023/20242.168 106 224 79 145 144 335 329 425 28 237 116 0
Totale 18.303